Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Nature Reviews Clinical Oncology

eISSN: 1759-4782pISSN: 1759-4774

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
63.5
Impact Factor
>= 25
SNIP
7.95

Journal Specifications

Overview
  • Publisher
    NATURE PORTFOLIO
  • Language
    English
  • Frequency
    Monthly
General Details
  • Language
    English
  • Frequency
    Monthly
  • Publication Start Year
    2004
  • Website URL
View less

Topics Covered

Oncology
Immunotherapy
Assay
Glioblastoma
Clinical trial
Breast cancer
Colorectal cancer
Antigen
Cancer susceptibility
Chimeric antigen receptor
Antibody-drug conjugate
Diffuse Glioma
Immune checkpoint inhibitors
Toxicity
Adjuvant therapy
Intraoperative radiotherapy
Cancer immunotherapy
Tumor microenvironment
Cell therapy
Lung cancer

Recently Published Papers

Year-wise Publication

FAQs

Since when has Nature Reviews Clinical Oncology been publishing? Faqs

The Nature Reviews Clinical Oncology has been publishing since 2004 till date.

How frequently is the Nature Reviews Clinical Oncology published? Faqs

Nature Reviews Clinical Oncology is published Monthly.

Who is the publisher of Nature Reviews Clinical Oncology? Faqs

The publisher of Nature Reviews Clinical Oncology is NATURE PORTFOLIO.

How can I view the journal metrics of Nature Reviews Clinical Oncology on editage? Faqs

For the Nature Reviews Clinical Oncology metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Nature Reviews Clinical Oncology? Faqs

The eISSN number is 1759-4782 and pISSN number is 1759-4774 for Nature Reviews Clinical Oncology.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Oncology, Immunotherapy, Assay, Glioblastoma, Clinical trial, Breast cancer, Colorectal cancer, Antigen, Cancer susceptibility, Chimeric antigen receptor, Antibody-drug conjugate, Diffuse Glioma, Immune checkpoint inhibitors, Toxicity, Adjuvant therapy, Intraoperative radiotherapy, Cancer immunotherapy, Tumor microenvironment, Cell therapy, Lung cancer.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.